Abstract：Objective To investigate the clinical efficacy of Naokang oral liquid in the treatment of secondary neuronal damage of patients with ischemic stroke.Methods A total of 100 ischemic stroke patients were recruited and randomly divided into study group and control group.Control group was treated with conventional medicine while study group was additionally given Naokang oral liquid. Twenty-eight days after treatment, the NIHSS score and MBI score were observed and recorded, while hemorheological changes were detected for each patient.Results Clinical symptoms of the two groups were significantly improved after treatment. After twenty-eight days of treatment, the NIHSS score in study group was decreased significantly, but the MBI score was higher than in control group, and the difference was statistically significant[(11.07±2.01)vs(14.95±1.85);(41.58±15.42)vs(36.24±13.56),P<0.05]. The hemorheological values in study group were reduced significantly compared with control group, and the difference was of statistical significance(P<0.05).Conclusions Naokang oral liquid can significantly improve the neurological function and daily activities of ischemic stroke patients. It can also remarkably improve patients’hemorheology and promote blood circulation of the brain.
姚响文, 王金余, 吴之琳, 牛筛龙. 脑康口服液治疗缺血性脑卒中后继发神经功能损害的疗效[J]. 武警医学, 2017, 28(3): 251-253.
YAO Xiangwen, WANG Jinyu, WU Zhilin, and NIU Shailong. Clinical efficacy of Naokang oral liquid in treatment of secondary neuronal damage of patients with ischemic stroke. Med. J. Chin. Peop. Armed Poli. Forc., 2017, 28(3): 251-253.
Li S Y, Gao Y, Ma W N, et al. The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population[J]. Inflammation, 2014,37(3):686-693.
[3]
Shadi Y, Andrew E, Joshua Z W. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator[J].JAMA Neurol,2014,71(9):1181-1185.
2017, Vol. 28 
